CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.20K | 7.70K | 15.10K | 13.60K | 45.70K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.70K | 3.50K | 3.30K | 5.00K | 5.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.90K | 11.20K | 18.40K | 18.60K | 50.70K |
|
|
|||||
| Total Current Assets | 14.90K | 11.20K | 18.40K | 18.60K | 50.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.90K | 11.20K | 18.40K | 18.60K | 50.70K |
|
|
|||||
| Total Accounts Payable | 43.50K | 45.60K | 49.30K | 41.20K | 62.90K |
| Total Accrued Expenses | 1.10M | 1.05M | 1.04M | -- | -- |
| Short-term Debt | 1.17M | 1.25M | 1.20M | 1.34M | 1.40M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 242.60K | 242.60K | 223.60K | 1.17M | 1.16M |
| Total Other Current Liabilities | 242.60K | 242.60K | 223.60K | 1.17M | 1.16M |
| Total Current Liabilities | 2.55M | 2.58M | 2.51M | 2.56M | 2.62M |
|
|
|||||
| Total Current Liabilities | 2.55M | 2.58M | 2.51M | 2.56M | 2.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.17M | 1.25M | 1.20M | 1.34M | 1.40M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.55M | 2.58M | 2.51M | 2.56M | 2.62M |
|
|
|||||
| Common Stock & APIC | 22.89M | 22.81M | 22.77M | 22.58M | 22.49M |
| Retained Earnings | -25.43M | -25.38M | -25.27M | -25.12M | -25.06M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.53M | -2.57M | -2.50M | -2.54M | -2.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.53M | -2.57M | -2.50M | -2.54M | -2.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.53M | -2.57M | -2.50M | -2.54M | -2.57M |
|
|
|||||